Scientia Research Institute

What Scientia Research Institute does

Scientia Research Institute is a Poland-based Contract Research Organization (CRO) headquartered in Bydgoszcz that delivers end-to-end clinical research services for pharmaceutical sponsors, biotechnology companies, and academic institutions. The firm operates 150+ active research centers across Poland and has completed more than 50 studies spanning therapeutic areas including oncology, hematology, cardiology, rare diseases, ATMP, CAR-T/CAR-NK, and pediatrics (the latter accounting for roughly 30% of projects). Its core service offering bundles medical writing, medical consulting, project management, site monitoring, biostatistics, quality control, pharmacovigilance, and data science, delivered as project-based contracts under ICH GCP E6 (R3) and E8 standards aligned with EMA and FDA requirements.

The technology platform centers on "modern clinical research technology" incorporating AI-based research models (exemplified by the PRINTGRAF project), telemedicine-enabled methodologies (SMART project for remote patient engagement), and IT tools for project implementation. Specialized expertise extends to advanced modalities such as Chimeric Antigen Receptor T-cell (CAR-T) and CAR-NK therapies, Advanced Therapy Medicinal Products including FOOTCELL, and rare disease studies. Scientia is currently registered as Scientia (legal name), operates as a private for-profit entity, and is independently owned with no disclosed parent company or external investor structure. The team composition is heavily credentialed — more than 40% of staff hold Ph.D.s and 100% hold current ICH-GCP certification — and team members also engage as academic lecturers and researchers with Polish and international medical universities.

The business model is professional services revenue generated through negotiated, project-based contracts with sponsors. Pricing is not publicly disclosed and is quote-based depending on therapeutic area, phase, scope, and duration. Customer segments are horizontal, spanning pharmaceutical sponsors (primary), biotechnology companies (primary, including co-development partners on CAR-T and ATMP programs), and academic institutions and research institutes (secondary, for investigator-initiated and collaborative studies). Geographic reach is anchored in Poland (nationwide coverage via 150+ active centers) with stated partnerships extending to Europe and the USA, supported by a bilingual Polish/English corporate website. No revenue, funding history, or named customer logos are disclosed in available source material, and the firm operates with a headcount in the 11–50 range.

Name

Scientia Research Institute

Legal name

Scientia

Website

https://scientiari.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Scientia Research Institute is a Poland-based Contract Research Organization (CRO) delivering end-to-end clinical trial services — including medical writing, monitoring, biostatistics, pharmacovigilance, and data science — to pharmaceutical sponsors, biotechnology companies, and academic institutions across 150+ active sites.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAL

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAAAI

Patient Recruitment, Site Feasibility & Trial Enablement CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAG

Medical Writing & Regulatory Submission Support CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAH

Pharmacovigilance, Risk Management & Medical Affairs CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAF

Clinical Data Management, Biostatistics & Statistical Programming CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Medical research consulting
• Pharmaceutical research

Headquarters

HQ city

Bydgoszcz

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: Comprehensive CRO services for organizing research projects including medical writing, consulting, project management, monitoring, biostatistics, quality control, and pharmacovigilance. Revenue generated through project-based contracts with pharmaceutical sponsors, biotechnology companies, and academic institutions for conducting clinical trials from early phases to advanced stages.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Scientia Research Institute is a Contract Research Organization (CRO) that provides comprehensive clinical research services across the whole of Poland, including clinical trial design, execution, monitoring, and regulatory compliance for both commercial and non-commercial research projects in adult and juvenile populations. The company delivers modular services including medical writing, consulting, project management, site monitoring, biostatistics, quality control, pharmacovigilance, and data science, supporting pharmaceutical sponsors, biotechnology companies, and academic institutions from early to advanced stages of drug and medical product development.

Product overview

Scientia Research Institute operates as a Contract Research Organization (CRO) offering a comprehensive, integrated suite of clinical research services. The core offering is the Clinical Research Services platform, supported by modular service components including Medical Writing, Medical Consulting, Project Management, Site Monitoring, Biostatistics, Quality Control, Pharmacovigilance, and Data Science Services. These services are designed to work together end-to-end, covering all phases of clinical trials from early development through advanced stages, supporting both commercial and non-commercial research projects across multiple therapeutic areas in Poland with international partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Research Services (CRO) Comprehensive Contract Research Organization (CRO) services covering the whole of Poland, offering clinical trial design, execution, monitoring, and regulatory compliance for commercial and non-commercial research projects across adult and juvenile populations, spanning all phases from early development to advanced stages.
• Medical Writing Preparation of clinical trial documentation including protocols, study plans, investigator brochures, final reports, product safety assessments, publications, posters, and regulatory submissions to bioethics committees and regulatory bodies, targeted at pharmaceutical sponsors and academic researchers.
• Medical Consulting Expert consultation services for clinical research projects including therapeutic area expertise, study design, and regulatory strategy aligned with ICH GCP E6 (R3) and E8 standards, for pharmaceutical, biotechnology, and academic clients.
• Project Management End-to-end project coordination covering planning, budgeting, contract processing, timeline management, and stakeholder communication for clinical trials across all phases of drug and medical product development.
• Site Monitoring On-site and remote monitoring services ensuring compliance with study protocols, regulatory requirements, and Good Clinical Practice standards across the network of 150+ active research centers.
• Biostatistics Statistical analysis services for clinical trial data including study design support, data analysis, and interpretation of results to support drug and medical product development programs.
• Quality Control Quality assurance services implementing continuous monitoring and risk analysis to ensure trials meet EMA and FDA standards and regulatory compliance requirements throughout the study lifecycle.
• Pharmacovigilance Drug safety monitoring services including adverse event reporting, safety assessments, and compliance with pharmacovigilance regulations throughout the product lifecycle.
• Data Science Services Innovative research data science services implementing modern technologies and analytical approaches to support evidence generation in clinical trials across diverse therapeutic areas.

Quantifiable outcome

• 50+ completed clinical research projects in critical therapeutic areas
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Biotechnology Companies (unspecified)coreStrategic or Co-development PartnerCollaboration with biotechnology companies on the development of CAR-T therapy treatment methods and other innovative therapeutic approaches including ATMP and AI-based medical solutions.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Medpace: Medpace is a mid-to-large full-service clinical CRO focused on therapeutic area depth across oncology, cardiology, and rare diseases. Directly comparable to Scientia in terms of full-service model and therapeutic-area orientation, but Medpace operates globally with significantly more resources.
• Cromsource: Cromsource is an international CRO headquartered in Europe, providing clinical research, biometrics, pharmacovigilance and staffing services. Comparable to Scientia as a European mid-market full-service CRO serving pharma and biotech sponsors across multiple therapeutic areas.
• PSI CRO: PSI CRO is a privately held mid-sized full-service clinical CRO with strong European presence and global reach across oncology, hematology, and rare diseases. Comparable to Scientia as a full-service European CRO competitor of similar operational model.
• Clinipace Worldwide: Clinipace Worldwide is a mid-market clinical CRO providing full-service clinical development, regulatory, and biostatistics services globally with therapeutic area focus. Comparable to Scientia as a mid-sized, therapeutically focused clinical CRO.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-market full-service CRO specializing in CNS, cardiometabolic, and rare disease trials. Comparable to Scientia as a mid-sized, therapeutically focused CRO operating across multiple regions with full Phase I–IV capabilities.
• Ergomed plc: Ergomed is a mid-sized clinical CRO with European heritage and growing U.S. presence, focused on oncology, rare disease, and orphan indications. Highly comparable to Scientia as a European-rooted CRO emphasizing therapeutic specialization and complex-therapy trial design.

Broad incumbents

• Syneos Health: Syneos Health is a large global clinical and commercial services organization providing full-service CRO and commercialization support. Comparable to Scientia as a full-service clinical CRO, though at significantly larger scale and broader geographic reach.
• Parexel International: Parexel is one of the largest global CROs, offering full-service clinical trial management, regulatory and post-approval services. Comparable to Scientia as a full-service CRO, though at global scale versus Scientia's Poland-centric mid-market footprint.
• IQVIA: IQVIA is the world's largest CRO and clinical research services provider, offering full-service Phase I–IV trial management, biostatistics, pharmacovigilance and consulting. Comparable to Scientia as a full-service clinical CRO serving pharma/biotech sponsors, though IQVIA operates at global scale while Scientia is a Poland-focused mid-market CRO.
• Charles River Laboratories: Charles River Laboratories is a large, publicly traded life sciences CRO providing clinical, preclinical, discovery, and manufacturing support. Comparable to Scientia in providing clinical CRO services to pharma/biotech, though Charles River operates at vastly larger scale and broader geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/scientia-research-institute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scientia Research Institute